Part of UT Health San Antonio
Part of the University of Texas System
Close Quicklinks
Please see the list of related pages below or use the site search to find the desired content.
... cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors. Cancer ... (>70 Years Old) Enrolled in Phase I Clinical Trials at University of Texas Health Science Center at San Antonio-Cancer Therapy ...
... (Chief Resident 09/2001 - 01/2003) - University of Calgary - Tom Baker Cancer Centre ... cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors. Cancer ...
... Life Science - School of Life Sciences, University of Hyderabad 1984 - ... of genetic, biochemical and molecular biology approaches to study cancers including melanoma, bladder and prostate cancers. Her team ...
... - Urology - Washington University School of Medicine - Barnes Hospital ... NIH/NCI/Southwest Oncology Group Title A Phase III Blinded Study Of Immediate Post-TURBT Instillation Of Gemcitabine Versus Saline In ...
... Website Section: Physicians EOS Low Dose Imaging Setting New Standards in Spine UT ...
... received his undergraduate and medical degrees from the University of Missouri. Between these, he completed his doctorate in molecular ... Oncology Group Title A Phase III Blinded Study Of Immediate Post-TURBT Instillation Of Gemcitabine Versus Saline In ...
... , the clinical practice of the School of Medicine at The University of Texas Health Science Center at San Antonio. Dr. Calhoon performed ... surgery, they often notice the scar on my chest, and it helps them relate to me. They are able to see I am fine, and that heart ...
... behind his eye.” Read the story The post News 4: Asher’s Avengers: hospital helps young boy fighting rare cancer ... UT Health San Antonio . Wednesday, March 27, 2019 news itemNews 4: Asher’s Avengers: hospital helps young boy fighting rare ...
... - Gene Regulation - The University of Texas MD Anderson Cancer Center ... and Ella Owens Med Rsch Foundation Title Potentiation of Gemcitabine activity in pancreatic cancer Status Active Period 6/2019 - 5/2020 ...
... tumors including prostate and pancreatic. Field of Study: Mechanism-based targeted interventions for effective management of ... 10/2019 - Present Individual Instruction University of Texas Health Science Center at San Antonio ...